Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Conduct a value comparison of no annual fee cash back cards to find the right one for your spending needs. Make informed choices.
25,387 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
As AI accelerates, the Microsoft-OpenAI relationship faces shifts. This piece explains why microsoft distancing itsel...
The Moana live-action remake opened to mixed signals: a top domestic ranking but weak sales that raise questions abou...
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Netflix faces a crossroads: expand by merging with major studios or double down on core strengths. This piece argues ...
Kadant is navigating 2025 with a mix of packaging strength and manufacturing headwinds. This guide breaks down what t...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
JPMorgan expands its institutional cash toolbox by assigning Ethereum and Solana to separate roles in a new on-chain ...
Toro's Q2 2026 earnings reveal how the company is balancing lawn and turf equipment demand with costs. This analysis ...
SpaceX fans and market watchers saw the stock quietly drift lower toward the mid-$120s. This piece breaks down why th...
A powerful stock rebound in META reshaped fortunes and sparked a closer look at risk, diversification, and wealth dyn...